International Business Machines CORP Form 4 insider transactions

NYSE
IBM Director Michael Miebach has increased his beneficial ownership of IBM common stock by deferring compensation into 310 Promised Fee Shares.
NYSE
An IBM director has deferred a portion of their compensation into 310 Promised Fee Shares, aligning their interests with shareholders through the company's deferred compensation plan.
NYSE
IBM Director Andrew Liveris has elected to defer a portion of his compensation into 331 Promised Fee Shares under the company's deferred compensation plan, increasing his beneficial ownership of derivative securities to 42,008.
NYSE
IBM Director Michelle J. Howard has deferred compensation into 279 Promised Fee Shares under the company's Board of Directors Deferred Compensation and Equity Award Plan, increasing her beneficial ownership to 15,189 shares.
NYSE
IBM Director Alex Gorsky acquired 365 Promised Fee Shares through a deferred compensation plan, increasing his total beneficial ownership to 32,213 derivative securities.
NYSE
IBM Director Marianne Catherine Brown deferred a portion of her compensation into 310 Promised Fee Shares, valued at $294.78 per share, under the company's deferred compensation plan.
NYSE
IBM Director David N. Farr acquired 196 Promised Fee Shares through a compensation deferral plan, increasing his beneficial ownership to 21,921 shares, with distribution deferred until retirement.
NYSE
An IBM director has elected to defer a portion of their compensation into 310 'Promised Fee Shares' under the company's deferred compensation plan, aligning their interests with shareholders.
NYSE
IBM Director Alfred W. Zollar has deferred fees into 310 Promised Fee Shares under the company's Deferred Compensation and Equity Award Plan, with distribution deferred until retirement.
NYSE
IBM Senior Vice President Robert David Thomas reported the vesting of the final tranche of his restricted stock units and the subsequent sale of shares for tax purposes on June 8, 2025.
NYSE
IBM Senior Vice President Nickle Jaclyn Lamoreaux reported the vesting of restricted stock units and subsequent tax-related share disposition, a routine compensation event.
NYSE
IBM's Chairman, President, and CEO, Arvind Krishna, increased his direct beneficial ownership of IBM common stock by 4,308 shares following the vesting of restricted stock units and a concurrent tax-related disposition.
NYSE
IBM's Senior Vice President and CFO, James J. Kavanaugh, reported changes in his direct common stock holdings due to the vesting of restricted stock units and subsequent tax-related share disposition.
NYSE
IBM's VP, Controller, Nicolas A. Fehring, reported the vesting of 500 restricted stock units and the subsequent sale of 262 shares to cover tax obligations on June 8, 2025.
NYSE
Director Alex Gorsky reports acquiring 433 shares of IBM common stock on March 31, 2025, through a deferral of fees under the IBM Board of Directors Deferred Compensation and Equity Award Plan.
NYSE
Director Marianne Brown reports acquisition of 367 shares of IBM common stock through a deferred compensation plan.
NYSE
Director Thomas Buberl reports acquisition of 367 shares of IBM common stock through the IBM Board of Directors Deferred Compensation and Equity Award Plan.
NYSE
Director David N. Farr reports acquiring 232 shares of IBM common stock through a deferred compensation plan.
NYSE
Director Michelle J. Howard reports acquisition of IBM common stock through a deferred compensation plan.
NYSE
Director Andrew N. Liveris reports acquiring 393 shares of IBM stock through a deferred compensation plan on March 31, 2025.
NYSE
Director Frederick William McNabb III reports acquiring 367 shares of IBM common stock through a deferred compensation plan on March 31, 2025.
NYSE
Director Michael Miebach reports the acquisition of 367 Promised Fee Shares of IBM common stock through deferral of fees under the IBM Board of Directors Deferred Compensation and Equity Award Plan.
NYSE
Director Martha E. Pollack reports acquisition of 232 shares of IBM common stock through the company's deferred compensation plan.
NYSE
Director Peter Voser reports acquiring 403 shares of IBM stock through a deferred compensation plan.
NYSE
Director Frederick H. Waddell reported the acquisition of 393 shares of IBM common stock through a deferred compensation plan.
NYSE
Director Alfred W. Zollar reports acquisition of 367 shares of IBM common stock through deferral of fees under the IBM Board of Directors Deferred Compensation and Equity Award Plan.
NYSE
IBM's VP, Controller Nicolas A. Fehring, reports a gift of 400 common stock shares.
NYSE
Senior Vice President Robert David Thomas sold 26,543 shares of IBM common stock at an average price of $253.0098 on March 3, 2025.
NYSE
Director David N. Farr purchased 1,200 shares of IBM common stock at $249 per share on February 28, 2025, increasing his direct holdings to 8,258 shares.
NYSE
Senior Vice President Robert David Thomas reports transactions involving IBM common stock, including the acquisition and disposal of shares related to restricted stock units.